Development of parapneumonic empyema in children

被引:36
作者
Lahti, Elina
Peltola, Ville
Virkki, Raimo
Alanen, Markku
Ruuskanen, Olli
机构
[1] Turku Univ Hosp, Dept Pediat, Turku 20500, Finland
[2] Turku Univ Hosp, Dept Radiol, FIN-20520 Turku, Finland
[3] Mehilainen Hosp, Dept Radiol, Turku, Finland
关键词
children; complicated pneumonia; empyema; parapneumonic effusion; pneumonia;
D O I
10.1111/j.1651-2227.2007.00511.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aim: The aim of the study was to find clinical predictors for parapneumonic empyema in children. Methods: Thirty-seven children treated for parapneumonic empyema at the Department of Pediatrics, Turku University Hospital, were retrospectively evaluated. Two distinct comparison groups of children with uncomplicated community-acquired pneumonia with alveolar consolidation (n = 37 in both groups) were included. Clinical and laboratory data on admission as well as fever kinetics and inflammatory markers during hospitalization were analyzed. Results: In a multivariate analysis, a history of prolonged fever, tachypnoea and pain on abdominal palpation on admission were the most significant clinical predictors for empyema. On admission, serum C-reactive protein levels were higher among children with empyema than among those with uncomplicated pneumonia (means, 234 mg/L vs. 178 mg/L; p = 0.037). During hospitalization, prolonged fever and persistence of high serum C-reactive protein levels were associated with empyema. At the initial evaluation, pleural fluid was not reported in 35% of children with empyema. Conclusions: Early recognition of developing empyema is challenging. Children with pneumonia presenting with prolonged fever, tachypnoea, pain on abdominal palpation and high serum C-reactive protein levels are at risk for parapneumonic empyema.
引用
收藏
页码:1686 / 1692
页数:7
相关论文
共 24 条
[1]  
ANDREWS NC, 1962, AM REV RESPIR DIS, V85, P935
[2]   BTS guidelines for the management of pleural infection in children [J].
Balfour-Lynn, IM ;
Abrahamson, E ;
Cohen, G ;
Hartley, J ;
King, S ;
Parikh, D ;
Spencer, D ;
Thomson, AH ;
Urquhart, D .
THORAX, 2005, 60 :1-21
[3]   An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: Risk factors and microbiological associations [J].
Byington, CL ;
Spencer, LY ;
Johnson, TA ;
Pavia, AT ;
Allen, D ;
Mason, EO ;
Kaplan, S ;
Carroll, KC ;
Daly, JA ;
Christenson, JC ;
Samore, MH .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (04) :434-440
[4]  
Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353
[5]   PARAPNEUMONIC PLEURAL EFFUSION AND EMPYEMA IN CHILDREN - REVIEW OF A 19-YEAR EXPERIENCE, 1962-1980 [J].
CHONMAITREE, T ;
POWELL, KR .
CLINICAL PEDIATRICS, 1983, 22 (06) :414-419
[6]  
DAGAN R, 1993, RESPIRATION, V60, P38
[7]   Clinical features, aetiology and outcome of empyema in children in the north east of England [J].
Eastham, KM ;
Freeman, R ;
Kearns, AM ;
Eltringham, G ;
Clark, J ;
Leeming, J ;
Spencer, DA .
THORAX, 2004, 59 (06) :522-525
[8]   Pneumococcal pleural empyemas in children [J].
Hardie, W ;
Bokulic, R ;
Garcia, VF ;
Reising, SF ;
Christie, CDC .
CLINICAL INFECTIOUS DISEASES, 1996, 22 (06) :1057-1063
[9]   Clinical manifestations and molecular epidemiology of necrotizing pneumonia and empyema caused by Streptococcus pneumoniae in children in Taiwan [J].
Hsieh, YC ;
Hsueh, PR ;
Lu, CY ;
Lee, PI ;
Lee, CY ;
Huang, LM .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (06) :830-835
[10]   Symptoms and signs of community-acquired pneumonia in children [J].
Juvén, T ;
Ruuskanen, O ;
Mertsola, J .
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2003, 21 (01) :52-56